These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 19618069)
1. Leprosy serology using PGL-I: a systematic review. Moura RS; Calado KL; Oliveira ML; Bührer-Sékula S Rev Soc Bras Med Trop; 2008; 41 Suppl 2():11-8. PubMed ID: 19618069 [TBL] [Abstract][Full Text] [Related]
2. Longitudinal assessment of anti-PGL-I serology in contacts of leprosy patients in Bangladesh. Richardus RA; van der Zwet K; van Hooij A; Wilson L; Oskam L; Faber R; van den Eeden SJF; Pahan D; Alam K; Richardus JH; Geluk A PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006083. PubMed ID: 29228004 [TBL] [Abstract][Full Text] [Related]
3. PGL-I leprosy serology. Bührer-Sékula S Rev Soc Bras Med Trop; 2008; 41 Suppl 2():3-5. PubMed ID: 19618067 [No Abstract] [Full Text] [Related]
4. Can anti-PGL-1 and anti-NDO-LID-1 antibody titers be used to predict the risk of reactions in leprosy patients? Devides AC; Rosa PS; de Faria Fernandes Belone A; Coelho NMB; Ura S; Silva EA Diagn Microbiol Infect Dis; 2018 Jul; 91(3):260-265. PubMed ID: 29669693 [TBL] [Abstract][Full Text] [Related]
5. Low predictive value of PGL-I serology for the early diagnosis of leprosy in family contacts: results of a 10-year prospective field study in French Polynesia. Chanteau S; Glaziou P; Plichart C; Luquiaud P; Plichart R; Faucher JF; Cartel JL Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):533-41. PubMed ID: 8151183 [TBL] [Abstract][Full Text] [Related]
6. A simple dipstick assay for the detection of antibodies to phenolic glycolipid-I of Mycobacterium leprae. Bührer SS; Smits HL; Gussenhoven GC; van Ingen CW; Klatser PR Am J Trop Med Hyg; 1998 Feb; 58(2):133-6. PubMed ID: 9502593 [TBL] [Abstract][Full Text] [Related]
7. Leprosy reactions: The predictive value of Mycobacterium leprae-specific serology evaluated in a Brazilian cohort of leprosy patients (U-MDT/CT-BR). Hungria EM; Bührer-Sékula S; de Oliveira RM; Aderaldo LC; Pontes AA; Cruz R; Gonçalves HS; Penna ML; Penna GO; Stefani MM PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005396. PubMed ID: 28222139 [TBL] [Abstract][Full Text] [Related]
8. Anti-PGL-1 Positivity as a Risk Marker for the Development of Leprosy among Contacts of Leprosy Cases: Systematic Review and Meta-analysis. Penna ML; Penna GO; Iglesias PC; Natal S; Rodrigues LC PLoS Negl Trop Dis; 2016 May; 10(5):e0004703. PubMed ID: 27192199 [TBL] [Abstract][Full Text] [Related]
9. Quantitative relationship between anti-PGL-I-specific antibody levels and the lepromin reaction. David HL; Maroja M F; Cruaud P Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):332-4. PubMed ID: 2071994 [No Abstract] [Full Text] [Related]
10. Assessment of anti-PGL-I as a prognostic marker of leprosy reaction. Stefani MM; Martelli CM; Morais-Neto OL; Martelli P; Costa MB; de Andrade AL Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):356-64. PubMed ID: 9934362 [TBL] [Abstract][Full Text] [Related]
11. IgM antibodies to native phenolic glycolipid-I in contacts of leprosy patients in Venezuela: epidemiological observations and a prospective study of the risk of leprosy. Ulrich M; Smith PG; Sampson C; Zuniga M; Centeno M; Garcia V; Manrique X; Salgado A; Convit J Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):405-15. PubMed ID: 1890364 [TBL] [Abstract][Full Text] [Related]
12. Impact of PGL-I seropositivity on the protective effect of BCG vaccination among leprosy contacts: a cohort study. Düppre NC; Camacho LA; Sales AM; Illarramendi X; Nery JA; Sampaio EP; Sarno EN; Bührer-Sékula S PLoS Negl Trop Dis; 2012; 6(6):e1711. PubMed ID: 22724040 [TBL] [Abstract][Full Text] [Related]
13. Detection of antibodies to both M. leprae PGL-I and MMP-II to recognize leprosy patients at an early stage of disease progression. Wang H; Liu W; Jin Y; Yu M; Jiang H; Tamura T; Maeda Y; Makino M Diagn Microbiol Infect Dis; 2015 Nov; 83(3):274-7. PubMed ID: 26320400 [TBL] [Abstract][Full Text] [Related]
14. Production and characterization of peptide mimotopes of phenolic glycolipid-I of Mycobacterium leprae. Youn JH; Myung HJ; Liav A; Chatterjee D; Brennan PJ; Choi IH; Cho SN; Shin JS FEMS Immunol Med Microbiol; 2004 May; 41(1):51-7. PubMed ID: 15094167 [TBL] [Abstract][Full Text] [Related]
15. Serum IgA1 and IgM antibodies against Mycobacterium leprae-derived phenolic glycolipid-I: a comparative study in leprosy patients and their contacts. Chujor CS; Bernheimer H; Levis WR; Schwerer B Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):441-9. PubMed ID: 1890368 [TBL] [Abstract][Full Text] [Related]
16. Leprosy serology (ML Flow test) in borderline leprosy patients classified as paucibacillary by counting cutaneous lesions: an useful tool. Barreto JA; Nogueira ME; Diorio SM; Bührer-Sékula S Rev Soc Bras Med Trop; 2008; 41 Suppl 2():45-7. PubMed ID: 19618075 [TBL] [Abstract][Full Text] [Related]
17. The role of Mycobacterium leprae phenolic glycolipid I (PGL-I) in serodiagnosis and in the pathogenesis of leprosy. Spencer JS; Brennan PJ Lepr Rev; 2011 Dec; 82(4):344-57. PubMed ID: 22439275 [TBL] [Abstract][Full Text] [Related]
18. Demonstration of PGL I antigens in skin biopsies in indeterminate leprosy patients: comparison with serological anti PGL I levels. Huerre M; Desforges S; Bobin P; Ravisse P Acta Leprol; 1989; 7 Suppl 1():125-7. PubMed ID: 2503967 [TBL] [Abstract][Full Text] [Related]
19. The result patterns of ML Flow and ELISA (PGL-I) serologic tests in leprosy-endemic and non-endemic areas. Silva RC; Lyon S; Araos R; Lyon AC; Grossi MA; Lyon SH; Penido RA; Bührer-Sékula S; Antunes CM Rev Soc Bras Med Trop; 2008; 41 Suppl 2():19-22. PubMed ID: 19618070 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of a rapid serological test for leprosy classification using human serum albumin as the antigen carrier. Moura RS; Penna GO; Fujiwara T; Pontes MA; Cruz R; Gonçalves Hde S; Penna ML; Cardoso LP; Stefani MM; Bührer-Sékula S J Immunol Methods; 2014 Oct; 412():35-41. PubMed ID: 24983877 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]